Updated on 9 October 2013
Eli Lilly Senior Vice President Michael Harrington has said that the alleged thefts were ‘appalling and disappointing,' and vowed to seek justice.
"Lilly will aggressively pursue every legal remedy to protect and safeguard its scientific discoveries. This includes assisting law enforcement in prosecuting and holding accountable those attempting to steal Lilly's valuable research. The confidential information these former employees are accused of stealing relates to early stage clinical development of potential new medicines. While very serious, the theft does not significantly jeopardize our overall research and development pipeline. Lilly has always taken extensive measures to protect its intellectual property. These safeguards continue to be reined and adapted in light of an ever-changing threat landscape," Mr Harrington said in a press statement.